Molecular structure of benzodiazepine receptors.
Benzodiazepines bind to high affinity binding sites in brain and other tissues. One of the high affinity sites in brain possesses properties which make it a likely site of action for these drugs. Binding to the benzodiazepine receptor is saturable and stereospecific; a high degree of correlation can be made between binding to this site and the pharmacological potency of the benzodiazepines. Binding to the site is also enchanced in the presence of GABA, the brain's major inhibitory transmitter. Because of this allosteric activation of benzodiazepine binding and the known electrophysiological interactions of the benzodiazepines with GABA, it appears likely that the site of action of the benzodiazepines in the brain is a GABA receptor complex. Recent evidence indicates that this complex also contains an anion channel which is the site of action of some of the barbiturates and known cage convulsants. The purification of the proteins composing this complex has been carried out and the major proteins appear to be several proteins with molecular weights between 50-60 k daltons; some higher molecular weight subunits may also be present. The benzodiazepine receptor protein can be labeled with 3H-flunitrazepam which labels a protein of molecular weight about 50 k daltons. Proteolytic degradation of the photolabeled benzodiazepine receptor results in the formation of several peptides and one limiting peptide which has recently been purified. Knowledge of its structure should yield interesting information about the origins of the benzodiazepine receptor and provide a useful tool for further molecular studies.
D000345:Affinity Labels; D001923:Brain Chemistry / Q000187:drug effects; D006801:Humans; D010777:Photochemistry; D011487:Protein Conformation; D011963:Receptors, GABA-A / Q000032:analysis* / Q000187:drug effects
D000345:Affinity Labels; D011963:Receptors, GABA-A